Tuberculosis (TB) is one of the world’s biggest global health crises. Killing 1.5 million people in 2020, TB is the world’s second deadliest infectious disease after COVID-19 (WHO).

Obsolete treatments, the lack of an effective vaccine, and the lack of suitable diagnostic tools make it difficult to control the global TB epidemic.

Some gains have been made in recent years; the first new TB drugs in half a century and the trial of a shorter course of treatment for drug-resistant TB (DR-TB). But the harsh reality remains - 10 million people fell sick with TB in 2020 and nearly half a million developed DR-TB, which is much harder to treat. Only about one-third of people with DR-TB accessed treatment in 2020. The majority go undiagnosed and therefore untreated.

IN 2021

Quick facts about Tuberculosis


MSF HIV/TB clinical guide for primary care

MSF medical resource 3 Feb 2023

MSF HIV/TB Guide: Hospital Level

MSF medical resource 3 Feb 2023
MSF Pharmacist dispensing Bedaquiline and Delamanid based DRTB
Multi-drug Resistant Tuberculosis

TB-PRACTECAL: Groundbreaking MSF trial finds better treatment for people with drug-resistant tuberculosis

Press Release 21 Dec 2022
MSF, Doctors without Borders, Daily dosage of pills
Multi-drug Resistant Tuberculosis

Major opportunity to increase access to newer, safer DR-TB drugs is at risk

Press Release 7 Nov 2022
Phenduka Mtshali, an DR-TB patient in Eshowe, KwaZulu Natal, South Africa
Multi-drug Resistant Tuberculosis

MSF calls for scale up of shorter and safer DR-TB treatments to help save more lives

Press Release 27 Oct 2022
MSF, Doctors without borders, Eshowe Rural COVID-19 Response
Global health

How the upcoming Global Fund replenishment decides who will be saved in the face of the HIV, TB and malaria pandemics, and why the pledges on September 21 matter.

Op-Ed 16 Sep 2022